Cervical pregnancy is a rare, potentially life-threatening condition that presents challenging management options. We report the cases of two patients: a 38-year-old, gravida 11 para 8+ 2 who presented with fi rst-trimester vaginal bleeding and a 32-year-old female primigravida who presented in her ninth week of gestation with vaginal spotting and abdominal pain. Radiological and histopathological fi ndings were consistent with cervical pregnancy in both cases, which were managed successfully with diff erent approaches. Conservative management with intra-embryonic injection of potassium chloride was successful in the fi rst case while dilatation and curettage aft er intramuscular methotrexate administration resolved the second patient's symptoms. Cervical pregnancy, when diagnosed early, can be successfully treated with medical therapy. Surgical intervention may be necessary, but adopting medical treatment as a fi rst line therapeutic option off ers the advantage of uterine preservation.
INTRODUCTION
Ectopic pregnancy is a rare condition that occurs in 1-2% of pregnancies [1] . Th e fallopian tubes are reported to be the commonest site of implantation [2] . In less than one percent of these cases, the cervix is the site of implantation [3] . In the past, cervical pregnancy (CP) was diagnosed when dilation and curettage (D&C) for a suspected incomplete abortion resulted in unexpected hemorrhage [4] . However, CP can now be more easily and accurately diagnosed with a fi rsttrimester ultrasound examination. As a result, therapeutic options have expanded with the use of ultrasound guided local injections and aspirations [3] . Ectopic pregnancies carry a zero prognosis for the baby and are also a cause of maternal mortality and morbidity [5] . In some cases, cervical blood vessels are destroyed, and an emergency hysterectomy may be indicated solely to increase the patient's chance of survival [3] . Th us, clinicians should be more knowledgeable about this condition, as early diagnosis can lead to better management and prognosis.
Until now, there has been no consensus regarding the optimal therapeutic approach to CP. However, conservative management based primarily on the use of methotrexate remains the primary protocol [6] . Th is paper describes two cases of CP that were managed successfully with intraembryonic injection of potassium chloride (KCL) in one case and D&C aft er intramuscular methotrexate administration in the other patient.
CASE PRESENTATION

Case 1
A 38-year-old Saudi female (G11P8+2) was admitted to King Abdulaziz University Hospital with per-vaginal bleeding and amenorrhea of six weeks and six days. Th e bleeding was painless and associated with minimal clots. Her medical history was unremarkable; her surgical history was only remarkable for a cesarean section (CS) performed four years prior and two D&C procedures.
On examination, the patient's vital signs were stable. Her abdomen was soft and lax, but there was mild tenderness in the suprapubic region. A vaginal examination was not done. An ultrasound revealed an empty uterus with a bulky cervix, and the endometrium measured 1.18 cm. A gestational sac with a single viable fetal pole (crown-rump length of 2.45 cm, equivalent to nine weeks and two days gestation) was observed in the cervix.
Conservative treatment was off ered. Under general anesthesia, the patient was placed in lithotomy position, cleaned and draped in the usual sterile manner. Aft er insertion of a Sim's speculum, an examination was performed, and the anterior cervical lip was held with a tenaculum. Under transvaginal ultrasound guidance, KCL 0.5 mL was injected into the gestational sac, resulting in the expulsion of the pregnancy. Th e conception products were sent for histopathological examination.
Th e patient tolerated the procedure well and was transferred to the ward. Post-procedure treatment included oral antibiotics and methotrexate. On day 1 postprocedure, the patient was stable, and she only experienced mild vaginal bleeding. A repeat β-hCG showed a level of 13724.8 mIU/L three days aft er her admission. Results of histopathology showed a gestational sac and placental tissue. Ten days aft er admission, her β-hCG level had fallen to 402.3 mIU/L.
Case 2
A 32-year-old primigravid Sudanese (gestational age, 9 weeks + 5 days) presented with vaginal spotting and abdominal pain. Her medical history was only signifi cant for bronchial asthma while her surgical history was unremarkable.
On physical examination, she was hemodynamically stable. Aft er an initial assessment and fetal ultrasound, a provisional diagnosis was made for CP and possible uterine didelphys.
Th e results of laboratory investigations were as follows: βhCG, 151497.5 mIU/L; white blood cell, 11.9 x 10 9 /L; hemoglobin, 12.5 g/dL; hematocrit, 40.4%; platelets: 311 x 103/μL; blood group, B Rhesus positive; hepatitis B surface antigen, negative; immunoglobulin M toxoplasma antibodies, 257.9 IU/mL; immunoglobulin G rubella antibodies, 246.6 IU/mL; sodium, 127 mEq/L; potassium, 3.5 mEq/L; urea, 2.2 mmol/L; creatinine, 61 μmol/L; prothrombin time, 11s; and partial prothrombin time, 25.2s. A pelvic ultrasound revealed a gestational sac with a single viable fetal pole (crown-rump length of 2.45 cm, equivalent to nine weeks and two days gestation) in the cervix. Magnetic resonance imaging fi ndings were also consistent with CP, showing minimal extension of the gestational sac into the lower uterine segment and no uterine anomalies.
Conservative management was given. Under general anesthesia, the patient was placed in lithotomy position, cleaned and draped in sterile manner. Th e cervix was held with a tenaculum, and dilatation and suction was done. Th e evacuated product was sent for histopathological examination, and curettage was subsequently performed. No active bleeding was observed during the procedure, which the patient tolerated. She was transferred to the recovery room in a satisfactory condition.
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Post-operative treatment included misoprostol 800 mcg. On the fi ft h day of admission, the patient's βhCG level fell to 32792.9 mIU/L and histopathological examination results showed the specimen comprised products of conception. On the sixth day of admission (day 2 postsurgery), the patient presented no complaints and her physical examination was unremarkable. A further drop of her βhCG level was observed as follows: 1090.2 mIU/L on day 17 post-surgery, 210.7 mIU/L on day 24 post-surgery, and 4.5 mIU/L two months aft er surgery.
DISCUSSION
Th e etiology of CP is still unknown; however, it may be associated with many factors, including prior instrumentation, D&C, pre-pregnancy smoking, previous pelvic surgery, CS or ectopic pregnancy, pelvic infl ammatory disease, advanced age, in vitro fertilization, intrauterine device use, and low parity [2, 7] . Th e fi rst patient in our report had a history of CS and two D&C procedures; the second patient was primigravid.
Both patients in our report had painless vaginal bleeding, which is the most common presenting symptom of ectopic pregnancy, especially in the fi rst trimester [2, 7, 8] .
Abdominal pain and hemodynamic instability have been reported in more severe cases, comprising less than one third of patients with CP [2, 7] . Findings of an enlarged, globular or distended cervix with external os dilatation can also be documented during admission [9] . Several factors determine the therapeutic approach, including the gestational age and viability of the fetus, the presence of active hemorrhage, the patient's request for future fertility and the physician's personal experience using methotrexate [10] . Th erefore, clinicians have to carefully choose candidates for medical intervention alone because of the rarity of the condition. Patients who may receive medical treatment alone must: (a) be hemodynamically stable, (b) be willing to comply with post-treatment monitoring, and (c) have pre-treatment serum β-HCG levels ≤ 5,000 mIU/mL [10] . We chose medical intervention in the fi rst patient, who was hemodynamically stable. Although the second patient was also hemodynamically stable, we opted for methotrexate administration followed by D&C owing to the absence of signifi cant vaginal bleeding and the relatively young gestational age.
Cervical pregnancy can be eff ectively treated with methotrexate without the need for D&C [6] . Some authors [10, 11] have described a success rate of 81.3% in patients treated with local methotrexate. Intra-amniotic methotrexate instillation, when used alone or conjoined with other conservative methods, yielded a success rate of approximately 90% in women with CP [10, 12] . Systemic methotrexate in multiple doses has been recommended in fi rst trimester pregnancies and in cases where fetal viability is absent. Otherwise, treatment would be associated with increased failure rates [9] . In a retrospective study by Song et al. [13] , only nine out of 30 cases of CP treated with intramuscular methotrexate did not require curettage. In one report by Mangino et al. [14] , hysteroscopy was performed in patients with CP following ineff ective treatment with intra-amniotic methotrexate. Furthermore, Pereira et al. [15] demonstrated a case of residual pregnancy three months aft er CP treatment with intramuscular methotrexate, intra-amniotic KCL injection and uterine artery embolization, indicating that close follow up is essential to ensure complete resolution of the pregnancy. Leeman and Wendland [4] stated that conservative treatment of CP was more effi cient if administered before 12 weeks of gestation, as the wall of the cervical canal was not deeply invaded by trophoblast cells. Irrespective of the regimen of choice, a fall in serum or urine β-hCG levels correlates well with successful therapeutic intervention, as demonstrated in our cases.
Finally, although CP is a rare condition, it can be successfully treated with conservative medical therapy when diagnosed early. Surgical intervention may be necessary, but conservative medical treatment as the fi rst line therapeutic option is safe and eff ective as it decreases morbidity. Conservative treatment further off ers the advantage of uterine preservation, thereby improving future fertility.
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